Since serum levels of inflammatory markers (IL-6, IL-8, TNF-α) are significantly reduced after 3 months of CPAP therapy, clinicians may consider it in OSA patients who respond poorly to treatments for the associated eye diseases [82]. The gene discussed is IL6; the disease is eye disorder.